Literature DB >> 23017226

Spectrum of antimicrobial activity associated with ionic colloidal silver.

Kira Morrill1, Kathleen May, Daniel Leek, Nicole Langland, La Deana Jeane, Jose Ventura, Corey Skubisz, Sean Scherer, Eric Lopez, Ephraim Crocker, Rachel Peters, John Oertle, Krystine Nguyen, Scott Just, Michael Orian, Meaghan Humphrey, David Payne, Bertram Jacobs, Robert Waters, Jeffrey Langland.   

Abstract

OBJECTIVES: Silver has historically and extensively been used as a broad-spectrum antimicrobial agent. However, the Food and Drug Administration currently does not recognize colloidal silver as a safe and effective antimicrobial agent. The goal of this study was to further evaluate the antimicrobial efficacy of colloidal silver.
DESIGN: Several strains of bacteria, fungi, and viruses were grown under multicycle growth conditions in the presence or absence of ionic colloidal silver in order to assess the antimicrobial activity.
RESULTS: For bacteria grown under aerobic or anaerobic conditions, significant growth inhibition was observed, although multiple treatments were typically required. For fungal cultures, the effects of ionic colloidal silver varied significantly between different genera. No viral growth inhibition was observed with any strains tested.
CONCLUSIONS: The study data support ionic colloidal silver as a broad-spectrum antimicrobial agent against aerobic and anaerobic bacteria, while having a more limited and specific spectrum of activity against fungi.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23017226     DOI: 10.1089/acm.2011.0681

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  6 in total

1.  Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model.

Authors:  Ingrid L Bergin; Laura A Wilding; Masako Morishita; Kim Walacavage; Andrew P Ault; Jessica L Axson; Diana I Stark; Sara A Hashway; Sonja S Capracotta; Pascale R Leroueil; Andrew D Maynard; Martin A Philbert
Journal:  Nanotoxicology       Date:  2015-08-24       Impact factor: 5.913

2.  Repeated dose (28-day) administration of silver nanoparticles of varied size and coating does not significantly alter the indigenous murine gut microbiome.

Authors:  Laura A Wilding; Christine M Bassis; Kim Walacavage; Sara Hashway; Pascale R Leroueil; Masako Morishita; Andrew D Maynard; Martin A Philbert; Ingrid L Bergin
Journal:  Nanotoxicology       Date:  2015-11-02       Impact factor: 5.913

3.  Intestinal microbiome of broiler chickens after use of nanoparticles and metal salts.

Authors:  Еlena Yausheva; Sergey Miroshnikov; Еlena Sizova
Journal:  Environ Sci Pollut Res Int       Date:  2018-04-24       Impact factor: 4.223

Review 4.  Efficacy of antimicrobial medicated ventricular catheters: a network meta-analysis with trial sequential analysis.

Authors:  Revanth Goda; Akshay Ganeshkumar; Varidh Katiyar; Ravi Sharma; Hitesh Kumar Gurjar; Aprajita Chaturvedi; Roshan Sahu; Hitesh Inder Singh Rai; Zainab Vora
Journal:  Neurosurg Rev       Date:  2021-05-19       Impact factor: 3.042

Review 5.  Nanosilver: new ageless and versatile biomedical therapeutic scaffold.

Authors:  Shahid Ullah Khan; Tawfik A Saleh; Abdul Wahab; Muhammad Hafeez Ullah Khan; Dilfaraz Khan; Wasim Ullah Khan; Abdur Rahim; Sajid Kamal; Farman Ullah Khan; Shah Fahad
Journal:  Int J Nanomedicine       Date:  2018-02-02

Review 6.  Silver nanoparticles as a potential treatment against SARS-CoV-2: A review.

Authors:  Fernanda Pilaquinga; Jeroni Morey; Marbel Torres; Rachid Seqqat; María de Las Nieves Piña
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2021-02-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.